In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

Gene Editing Delivery Summit

Oct 24, 2023 - 09:00 AM - Oct 26, 03:30 PM
Embassy Suites by Hilton Boston at Logan Airport
207, Porter St

ZIP: 02128
Phone: +1 617 455 4188

Ticket Price: USD 2599.00 - USD 5297.00

Are you refining and optimizing your in vivo gene editing delivery strategies for the next generation of gene editors to unlock increased therapeutic efficacy, safety, and cost effectiveness?

Recent clinical trial successes from the likes of Editas Medicine and Tessera Therapeutics have highlighted the importance of targeted delivery for the safety and efficacy of in vivo gene editing. Formulation and delivery experts are uniting to evaluate and optimize cutting edge delivery strategies including LNPs, AAVs, exosomes, peptide shuttles, and polymer nanoparticles at the Gene Editing Delivery Summit. Leverage this insight to supercharge precise and efficient extra-hepatic in vivo gene editing to patients with previously untreatable genetic diseases.

Take advantage of the end-to-end content from discovery, optimization, evaluation, and scale-up topics covered in 2 hands-on workshops and 2 full days of data-driven case studies and discussion sessions from trailblazing drug developers such as Prime Medicine, Beam Therapeutics, Editas Medicine, and AstraZeneca to guide your in vivo gene editing delivery strategies for regulatory approval.

Join us in at the Gene Editing Delivery Summit in October to gain practical insights for your discovery, development, optimization, and engineering of delivery systems for your gene editor of choice for targets beyond the liver to accelerate into the clinic.

Tickets: https://go.evvnt.com/1834795-2?pid=1052
Brochure: https://go.evvnt.com/1834795-3?pid=1052

Drug Developer - Conference + 2 Workshops: USD 4297.00,
Drug Developer - Conference + 1 Workshop: USD 3648.00,
Drug Developer - Conference Only: USD 2999.00,
Academic and Research - Conference + 2 Workshops: USD 3697.00,
Academic and Research - Conference + 1 Workshop: USD 3148.00,
Academic and Research - Conference Only: USD 2599.00,
Service Provider - Conference + 2 Workshops: USD 5297.00,
Service Provider - Conference + 1 Workshop: USD 4548.00,
Service Provider - Conference Only: USD 3799.00

Speaker Details

Anna (Xue) Cheng, Director of R and D Pulmonary Delivery, Feldan Therapeutics, David Guay, Vice President Technology and Innovation, Feldan Therapeutics, Delai Chen, Director of Nanoparticle Formulation, Beam Therapeutics, Jerrin George, HFSP Postdoctoral Fellow, Columbia University Irving Medical Center Sternberg Lab, Jessie Davis, Senior Scientist, Prime Medicine, Joe Nabhan, Chief Scientific Officer, Vesigen Therapeutics, John Zuris, Director of Gene Editing Technologies, Editas Medicine, Katherine Cook, Scientist, Tessera Therapeutics, Kelly Banas, Principal Investigator, ChristianaCare Gene Editing Institute, Marine Hatit, Senior Scientist I – LNP Discovery Lead, Prime Medicine, Nageswara Rao Kollu, Senior Director, Apellis Pharmaceuticals, P.J. Brooks, Acting Director, Division of Rare Disease Research Innovation, NCATS NIH, Robert Bell, Senior Vice President and Head of Research, Ascidian Therapeutics, Roland Baumgartner, Senior Director - Research and Development, Artisan Cells, Saumyaa Saumyaa, Associate Director, AstraZeneca, Sourav Choudhury, Head of AAV Technologies, Sanofi Genomic Medicines Unit, Susan Rosenbaum, Founder, Chairman and Chief Executive Officer, Lauren Sciences LLC, Wes Salomon, Director of Delivery Biology, Tessera Therapeutics

Event Categories
Keywords: Health , science


Events Calendar

1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4

Event Location


VIP Life Time Subscription to our Newsletters!